Critical review: assessment of interferon-β immunogenicity in multiple sclerosis

Keyphrases

• Multiple Sclerosis 100%
• Neutralizing Antibodies 100%
• Interferon-α (IFN-α) 100%
• Personalized Medicine 100%
• Immunogenicity 100%
• Binding Antibodies 100%
• Review Assessment 100%
• Clinical Significance 50%
• Clinical Application 50%
• Pharmacokinetics 50%
• Detection Method 50%
• Therapy Optimization 50%
• Type I Interferon 50%
• Recombinant Interferon 50%
• Protein Drug 50%
• Prolonged Use 50%
• Anti-interferon Antibodies 50%
• Trial-and-error 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Sclerosis 100%
• Neutralizing Antibody 100%
• Interferon 100%
• Immunogenicity 100%
• Pharmacokinetics 50%
• Bioavailability 50%
• Interferon Antibody 50%
• Interferon Type I 50%
• Recombinant Interferon 50%

Immunology and Microbiology

• Multiple Sclerosis 100%
• interferon 100%
• Immunogenicity 100%
• Neutralizing Antibody 66%
• Binding Antibody 66%
• Pharmacokinetics 33%
• Recombinant Interferon 33%
• Interferon Antibody 33%